Overstock.com’s CEO denied reports the company suffered any significant losses because of a glitch in cryptocurrency systems, and said that, despite the media coverage, he still believes Bitcoin holds a lot of potential for the company.
“Right now we’re doing a tZero ICO raising $300 million...People are telling me that’s a business they think has a 3 billion or 4 billion value,” Patrick Byrne told Cheddar Friday.
“I literally have people on Wall St. saying, if I pull off the tZero ICO, and then over two years we do what we think we can do, they say that’s a $40 billion enterprise. People have no idea, yet how much of the financial system we intend to augment.”
Reports emerged earlier this week that a bug created a big opportunity for arbitrage, allowing customers to purchase items with Bitcoin Cash, which trades at roughly $2,500, and return them in exchange for Bitcoin, priced at more than $13,000.
Byrne said the issue was caused by the overwhelming trade volume at payment partner Coinbase. He claims the mix-up, which lasted milliseconds, did not result in any material losses.
For full interview [click here](https://cheddar.com/videos/overstock-ceo-responds-to-bitcoin-mix-up).
Tobacco manufacturers have started posting new warning signs about cigarettes in over 200,000 stores across the country, one of the final steps in a lawsuit filed by the Justice Department against Big Tobacco in 1999.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Ahead of the July 4th holiday weekend, flight delays and cancellations have impacted thousands across the country. Cheddar News checked in from New York's LaGuardia Airport for more.
Overstock.com CEO Jonathan Johnson joined Cheddar News after a bankruptcy court approved its purchase of Bed Bath & Beyond's digital and IP assets. Johnson looked ahead to what consumers can expect as those assets are absorbed into Overstock.com and what lies ahead overall.
